Avid Radiopharms Inc Drug Patent Portfolio
Avid Radiopharms Inc owns 2 orange book drugs protected by 3 US patents Given below is the list of Avid Radiopharms Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8932557 | Imaging agents for detecting neurological dysfunction | 26 May, 2032 | Active |
| US7687052 | Styrylpyridine derivatives and their use for binding and imaging amyloid plaques | 30 Apr, 2027 | Active |
| US8506929 | Styrylpyridine derivatives and their use for binding and imaging amyloid plaques | 30 Apr, 2027 | Active |
Latest Legal Activities on Avid Radiopharms Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Avid Radiopharms Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Patent Term Extension Certificate
Critical
| 18 Oct, 2023 | US8932557 |
| Notice of Final Determination -Eligible | 01 Sep, 2023 | US8932557 |
|
FDA Final Eligibility Letter
Critical
| 26 Apr, 2023 | US8932557 |
| transaction for FDA Determination of Regulatory Review Period | 30 Jun, 2022 | US8932557 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 22 Jun, 2022 | US8932557 |
| Second letter to regulating agency to determine regulatory review period | 05 Nov, 2021 | US8932557 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 30 Sep, 2021 | US7687052 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 15 Feb, 2021 | US8506929 |
| Letter from FDA or Dept of Agriculture re PTE application | 14 Dec, 2020 | US8932557 |
| Initial letter Re: PTE Application to regulating agency | 05 Nov, 2020 | US8932557 |
| Patent Term Extension Application under 35 USC 156 Filed | 28 Aug, 2020 | US8932557 |
| Patent Term Extension Application under 35 USC 156 Filed | 16 Jul, 2020 | US8932557 |
| Post Issue Communication - Certificate of Correction | 05 Jul, 2019 | US7687052 (Litigated) |
| Post Issue Communication - Certificate of Correction | 02 Jul, 2019 | US8506929 |
| Post Issue Communication - Certificate of Correction | 25 Mar, 2019 | US8506929 |
Avid Radiopharms Inc Drug Patents' Oppositions Filed in EPO
Avid Radiopharms Inc drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Oct 31, 2022, by Life Molecular Imaging Ltd.. This opposition was filed on patent number EP09711194A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP09711194A | Oct, 2022 | Life Molecular Imaging Ltd. | Granted and Under Opposition |
Avid Radiopharms Inc's Family Patents
Avid Radiopharms Inc Drug List
Given below is the complete list of Avid Radiopharms Inc's drugs and the patents protecting them.
1. Amyvid
Amyvid is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7687052 | Styrylpyridine derivatives and their use for binding and imaging amyloid plaques |
30 Apr, 2027
(2 years from now)
| Active |
| US8506929 | Styrylpyridine derivatives and their use for binding and imaging amyloid plaques |
30 Apr, 2027
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Amyvid's drug page
2. Tauvid
Tauvid is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8932557 | Imaging agents for detecting neurological dysfunction |
26 May, 2032
(7 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tauvid's drug page